Science Explorer Back to mapMap
Discussion
Company · Salt Lake City · United States

Arrien Pharmaceuticals (United States)

arrienpharma.comROR OpenAlex
Research works
77
▲ 59% vs 2018-21
Citations
4.2k
55.2 per fractional work
Top-10% rate
24.3%
all institutions 10.0%
Open access
28%
world 40%
International
26%
world 18%
Arrien Pharmaceuticals (United States)

Not ranked overall: Arrien Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Arrien Pharmaceuticals (United States) work in?

In all years, 48% of research at Arrien Pharmaceuticals (United States) is in Life Sciences, 41% in Health Sciences. Its largest fields are Medicine (37%), Biochemistry, Genetics and Molecular Biology (35%), Neuroscience (9%). It does 2.7× the world's share of Life Sciences.

Life Sciences: 37 fractional works · 48.2% of its workBiochemistry, Genetics and Molecular Biology: 27 fractional works · 35.1% of its workMolecular Biology: 21 fractional works · 27.1% of its workGenetics: 2 fractional works · 2.7% of its workCancer Research: 1 fractional works · 1.8% of its workCell Biology: 1 fractional works · 1.7% of its workBiophysics: 1 fractional works · 0.9% of its workPhysiology: 0 fractional works · 0.4% of its workClinical Biochemistry: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 7 fractional works · 9.5% of its workCellular and Molecular Neuroscience: 6 fractional works · 7.2% of its workSensory Systems: 1 fractional works · 0.7% of its workBiological Psychiatry: 0 fractional works · 0.4% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.4% of its workCognitive Neuroscience: 0 fractional works · 0.3% of its workDevelopmental Neuroscience: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 2 fractional works · 2.1% of its workInsect Science: 1 fractional works · 1.7% of its workPlant Science: 0 fractional works · 0.4% of its workImmunology and Microbiology: 1 fractional works · 1.1% of its workImmunology: 1 fractional works · 1.1% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.4% of its workHealth Sciences: 32 fractional works · 41.4% of its workMedicine: 28 fractional works · 37.2% of its workNephrology: 7 fractional works · 8.8% of its workOncology: 6 fractional works · 7.6% of its workPathology and Forensic Medicine: 3 fractional works · 3.4% of its workPulmonary and Respiratory Medicine: 2 fractional works · 2.8% of its workOrthopedics and Sports Medicine: 1 fractional works · 1.9% of its workPhysiology: 1 fractional works · 1.7% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 1.6% of its workGenetics: 1 fractional works · 1.5% of its workSurgery: 1 fractional works · 1.2% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.2% of its workNeurology: 1 fractional works · 1.2% of its workImmunology and Allergy: 1 fractional works · 1.1% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.5% of its workReproductive Medicine: 0 fractional works · 0.4% of its workEpidemiology: 0 fractional works · 0.3% of its workObstetrics and Gynecology: 0 fractional works · 0.2% of its workOphthalmology: 0 fractional works · 0.2% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.2% of its workRheumatology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.5% of its workNursing: 3 fractional works · 4.1% of its workNutrition and Dietetics: 3 fractional works · 4.1% of its workVeterinary: 0 fractional works · 0.1% of its workPhysical Sciences: 8 fractional works · 10.2% of its workChemistry: 4 fractional works · 5.5% of its workOrganic Chemistry: 2 fractional works · 2.8% of its workSpectroscopy: 2 fractional works · 2.0% of its workAnalytical Chemistry: 0 fractional works · 0.7% of its workEnvironmental Science: 1 fractional works · 1.7% of its workHealth, Toxicology and Mutagenesis: 1 fractional works · 0.8% of its workEnvironmental Chemistry: 0 fractional works · 0.7% of its workEcology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEngineering: 1 fractional works · 1.4% of its workBiomedical Engineering: 1 fractional works · 0.7% of its workMechanical Engineering: 0 fractional works · 0.7% of its workComputer Science: 1 fractional works · 1.1% of its workComputational Theory and Mathematics: 1 fractional works · 1.1% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 0.3% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 0 fractional works · 0.2% of its workPaleontology: 0 fractional works · 0.2% of its workMathematics: 0 fractional works · 0.0% of its workSocial Sciences: 0 fractional works · 0.1% of its workPsychology: 0 fractional works · 0.1% of its workALL ITS WORKArrienPharmaceuticals…77fractional works, all years
Life Sciences48%Physical Sciences10%Health Sciences41%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2735.1%
    2. Neuroscience79.5%
    3. Agricultural and Biological Sciences22.1%
    4. Immunology and Microbiology11.1%
    5. Pharmacology, Toxicology and Pharmaceutics00.4%
    1. Medicine2837.2%
    2. Nursing34.1%
    3. Veterinary00.1%
    4. Health Professions00.0%
    1. Chemistry45.5%
    2. Environmental Science11.7%
    3. Engineering11.4%
    4. Computer Science11.1%
    5. Materials Science00.3%
    6. Earth and Planetary Sciences00.2%
    7. Mathematics00.0%
    1. Psychology00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.56× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 8.25× its world share, 3 worksBiochemistry, Geneti…Neuroscience: 4.57× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.34× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.47× its world share, 0 worksChemistryComputer Science: 1.08× its world share, 1 worksComputer ScienceMaterials Science: 0.11× its world share, 0 worksMaterials ScienceMathematics: 0.17× its world share, 0 worksMathematicsMedicine: 1.76× its world share, 2 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 8.2×. Every wedge is a field page.

All 9 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology8.25×3 works
  2. Pharmacology, Toxicology and Pharmaceutics6.34×0 works
  3. Neuroscience4.57×1 works
  4. Medicine1.76×2 works
  5. Computer Science1.08×1 works
  6. Agricultural and Biological Sciences0.56×0 works
  7. Chemistry0.47×0 works
  8. Mathematics0.17×0 works
  9. Materials Science0.11×0 works

Who are the top researchers at Arrien Pharmaceuticals (United States)?

Ranked on the quality score, Edward F. Nemeth, John Fox and KIMBERLY V. ROGERS lead among researchers whose main affiliation is Arrien Pharmaceuticals (United States).

  1. 1 Edward F. Nemeth United States · #501,248 worldwide 7k citations · 118 works
  2. 2 John Fox United States · #1,107,279 worldwide 5k citations · 98 works
  3. 3 KIMBERLY V. ROGERS United States · #1,329,326 worldwide 1.8k citations · 27 works
  4. 4 Alan L. Mueller United States · #1,404,051 worldwide 1.9k citations · 42 works
  5. 5 Lance G. Hammerland United States · #1,487,740 worldwide 2k citations · 20 works
  6. 6 Eric G. DelMar United States · #1,890,242 worldwide 1.5k citations · 19 works
  7. 7 David S. Wells United States · #2,737,238 worldwide 648 citations · 22 works
  8. 8 Rebecca L. Conklin United States · #3,270,478 worldwide 583 citations · 15 works
  9. 9 Linda D. Artman United States · #3,351,171 worldwide 518 citations · 21 works
All ranked researchers at Arrien Pharmaceuticals (United States)

What are the most cited papers from Arrien Pharmaceuticals (United States)?

The most cited paper from Arrien Pharmaceuticals (United States) is "Towards the sustainable discovery and development of new antibiotics" (Marcus Miethke et al., 2021), with 1,192 citations. Next come "Calcimimetics with potent and selective activity on the parathyroid calcium receptor" (616) and "Molecular Cloning and Functional Expression of Human Parathyroid Calcium Receptor cDNAs" (504).

Most cited papers
#PaperReleasedCitations
1 Towards the sustainable discovery and development of new antibiotics Marcus Miethke et al. · Nature Reviews Chemistry ReviewOpen access 19 Aug 2021 1,192
2 Calcimimetics with potent and selective activity on the parathyroid calcium receptor Edward F. Nemeth, Michael E. Steffey, Lance G. Hammerland et al. · Proceedings of the National Academy of Sciences Open access 31 Mar 1998 616
3 Molecular Cloning and Functional Expression of Human Parathyroid Calcium Receptor cDNAs James E. Garrett, Irene V. Capuano, Lance G. Hammerland et al. · Journal of Biological Chemistry Open access May 1995 504
4 Expression and Characterization of Inactivating and Activating Mutations in the Human Ca2+-sensing Receptor Mei Bai, Steven J. Quinn, Sunita Trivedi et al. · Journal of Biological Chemistry Open access Aug 1996 430
5 Controlled Dimerization of ErbB Receptors Provides Evidence for Differential Signaling by Homo- and Heterodimers Senthil K. Muthuswamy, Michael Gilman, Joan S. Brugge · Molecular and Cellular Biology Open access Oct 1999 367
All 60 most cited papers, with filters and sorting

Which keywords describe research at Arrien Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Parathyroid Hormone, Chronic Kidney Disease, FGF23, phosphate, Cancer, Cancer Therapy, Cell Signaling and Breast Cancer.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Parathyroid Hormone8▲ 108×3 topics
  2. Chronic Kidney Disease7▲ 36×2 topics
  3. FGF237▲ 237×1 topic
  4. phosphate7▲ 237×1 topic
  5. Cancer6▲ 5.8×28 topics
  6. Inflammation5▲ 3.0×21 topics
  7. Cancer Therapy5▲ 11×9 topics
  8. Cell Signaling5▲ 20×7 topics
  9. Breast Cancer5▲ 22×4 topics
  10. Ion Channels4▲ 25×2 topics
  11. Cardiovascular Disease4▲ 4.7×4 topics
  12. Neuronal Circuits4▲ 26×2 topics
  13. Oxidative Stress4▲ 2.7×15 topics
  14. Calcium Channels4▲ 65×1 topic
  15. Voltage-Gated Channels4▲ 65×1 topic
  16. Ion Channel4▲ 115×2 topics
  17. Neurological Disorders3▲ 6.4×4 topics
  18. Synaptic Plasticity3▲ 14×2 topics
  19. GABAergic3▲ 30×1 topic
  20. Neurotransmission3▲ 30×1 topic
  21. Prostate Cancer3▲ 27×3 topics
  22. Cancer Treatment3▲ 15×2 topics
  23. Clinical Practice Guidelines3▲ 6.9×2 topics
  24. Bisphosphonates3▲ 97×1 topic
  25. Gene Expression3▲ 6.1×7 topics
  26. Osteonecrosis of the Jaw3▲ 97×1 topic
  27. Immune System3▲ 10×3 topics
  28. Metabolic Syndrome3▲ 3.9×5 topics
  29. Transcriptional Regulation3▲ 14×5 topics
  30. Calcium Signaling2▲ 25×2 topics
  31. Insulin Signaling2▲ 25×3 topics
  32. Diabetes2▲ 6.0×3 topics
  33. Nutrition2▲ 7.0×2 topics
  34. Magnesium2▲ 241×1 topic
  35. TRPM72▲ 241×1 topic
  36. Tumor Suppression2▲ 25×3 topics
  37. Epigenetic Regulation2▲ 13×4 topics
  38. Cell Migration2▲ 31×2 topics
  39. Protein Kinases2▲ 88×1 topic
  40. Ras Signaling2▲ 88×1 topic

Which research topics does Arrien Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Advanced Breast Cancer Therapies, Computational Drug Discovery Methods, Single-cell and spatial transcriptomics and RNA modifications and cancer.

Advanced Breast Cancer T…1Advanced Breast Cancer Therapies: 1 fractional worksComputational Drug Discovery Methods: 1 fractional worksSingle-cell and spatial transcriptomics: 0 fractional worksRNA modifications and cancer: 0 fractional worksCell Image Analysis Techniques: 0 fractional worksPARP inhibition in cancer therapy: 0 fractional worksCancer Genomics and Diag…0Cancer Genomics and Diagnostics: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksGlutathione Transferases and Polymorphisms: 0 fractional worksPharmacogenetics and Drug Metabolism: 0 fractional works
Pulmonary and Respiratory MedicineComputational Theory and MathematicsMolecular BiologyBiophysics3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  2. 2 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
  3. 3 Single-cell and spatial transcriptomics Molecular Biology 0 works
  4. 4 RNA modifications and cancer Molecular Biology 0 works
  5. 5 Cell Image Analysis Techniques Biophysics 0 works
  6. 6 PARP inhibition in cancer therapy Oncology 0 works
  7. 7 Cancer Genomics and Diagnostics Cancer Research 0 works
  8. 8 Cancer Immunotherapy and Biomarkers Oncology 0 works
  9. 9 Glutathione Transferases and Polymorphisms Molecular Biology 0 works
  10. 10 Pharmacogenetics and Drug Metabolism Pharmacology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available28.2%not open71.8%

World: 40% of research is openly available.

with international co-authors25.6%domestic only74.4%

World: 18% is written across borders.

How has Arrien Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 59% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Arrien Pharmaceuticals (United States) as a percentage of every work published that year, 0.000035% in 2024.

still counting0.00050%0.0010%Arrien Pharmaceuticals (United States)0.000032% in 2025200020102020

Fractional works of Arrien Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Salt Lake City

All research institutions in Salt Lake City

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Arrien Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.